On December 3, 2021, SYM Medical was selected into the list of 2021 “specialized, special-new” enterprises in Guangdong province.

"Specialized and special new" enterprises refer to enterprises with the characteristics of "specialization, refinement, characteristics, and novelty", and are an important force in promoting social and economic development. SYM Medical is honored to receive this award which fully reflects SYM medical’s R&D advantages and brand influence in the field of neurology.
 

Since SYM Medical’s strategic transformation in 2015, it has established an open and mutually beneficial incubation platform (SYM-LAB) focusing on neurosurgery. SYM-LAB cooperates with neurosurgeons to provide resources such as scientific research, funding, registration, production and sales, to promote the transformation of innovative medical ideas or patents into marketed products in the shortest time for the benefit of patients.